The PKD Foundation engages with the research community in several ways.
- Through our researcher newsletter, researchers can opt-in to receive notifications about funding opportunities (funding from the PKD Foundation and external partners), educational opportunities, events, ongoing research, and more.
- For researchers seeking participants for clinical trials, studies can be submitted to us for consideration and promotion through our ACT Alerts program.
- Through the PKD Outcomes Consortium (PKDOC), the PKD Foundation collaborates with the Critical Path Institute, representatives of the pharmaceutical industry, PKD clinicians, and the U.S. Food and Drug Administration (FDA). Together, they facilitate clinical trial development for PKD therapies by establishing a clear regulatory pathway for the pharmaceutical industry to evaluate the effectiveness of potential treatments.